Damages In Little-Known Biotech Suit Reach Record Level
In the epilogue to an acrimonious battle over a drug that could be worth billions of dollars, a federal jury has ordered a California biotechnology company to pay an additional $30...To view the full article, register now.
Already a subscriber? Click here to view full article